We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Roughly three-quarters of women enrolled in the trial saw a 50 percent or greater reductions from baseline in menstrual blood loss volume during the last 35 days of treatment. Read More
The small-scale trial will include up to 90 healthy adult volunteers age 18 to 30 years who will be exposed to the virus in a controlled setting. Read More
Eurofins said that the test can distinguish between vaccinated patients and patients who had an asymptomatic infection before or after inoculation. Read More